Radiotherapy With Chemotherapy as Neoadjuvant Therapy of Resectable and Borderline Resectable Pancreas Cancer
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine safety and to obtain preliminary estimates of the
rate of major pathologic response of neoadjuvant accelerated fraction, standard dose
radiation given with chemotherapy in patients with locally advanced pancreas cancer.